Questions? Visit the CDO Welcome Desk or email us at askcdo@mit.edu.  | CDO Welcome Desk Hours: M-F, 9am-4pm (Note - Summer Hours start June 3: M-TH, 9am-4pm) | The Virtual Interview Room is available for spring and summer bookings!

Bio / Pharma / Healthcare

Skyhawk Therapeutics nabs Peloton exec and cancer R&D veteran as VP of oncology biology

Two months after Merck announced a billion-dollar-plus deal to buy out late-stage cancer biotech Peloton, some of its staffers are finding new homes.

This is good news for RNA startup Skyhawk Therapeutics, which has nabbed Peloton’s former VP of biology, 

By MIT Sloan CDO
MIT Sloan CDO
Read more

Facebook rolls out new disease prevention mapping tools

The company is releasing three types of maps meant to help public health organizations stay ahead of disease outbreaks and guide disaster response: population density maps, movement maps and network coverage maps.

Continue reading on MedCityNews

By MIT Sloan CDO
MIT Sloan CDO
Read more

MorphoSys builds out U.S. infrastructure for anticipated launch of lymphoma drug

The German drugmaker plans to submit its data package for FDA approval by the end of the year, with potential approval next year. The package will include a synthetic control arm comprising real-world data.

Continue reading on MedCityNews

By MIT Sloan CDO
MIT Sloan CDO
Read more

Sidebar